Risks listed by the department The advisory enumerates specific risks associated with unauthorized or counterfeit products, including: containing too much, too little, or none of the active ingredient [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized] containing unlisted, dangerous or unknown ingredients [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized] containing contaminants such as solvents, heavy metals, particles, or microbials [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized] being poorly or incorrectly labelled, or improperly manufactured or stored [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized] Health Canada adds that unauthorized injectable products carry additional risks such as infections due to lack of sterility, allergic reactions, and other serious negative outcomes due to contamination, improper handling, or unsafe administration [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized]
Sesame and Costco have already teamed up to offer healthcare services, including virtual primary care starting at $29 for Costco members, health checkups including lab work for $72, and virtual mental health therapy for $79
Blog Medicaid GLP-1 Coverage in 2026: Which States Pay for Weight Loss Medication Quick Answer Only 13 state Medicaid programs pay for GLP-1 medications like Wegovy and Zepbound when prescribed for weight loss in 2026
Future generic timing can differ by country and regulatory system
The FDA does not review the safety and efficacy of compounded products, which are custom-made alternatives to brand drugs designed to meet a specific patients needs
)
